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INTRODUCTION 47
Filoviruses are nonsegmented, negative-stranded RNA viruses grouped into 48 two genera, Marburgvirus and Ebolavirus. These filoviruses are known to cause severe 49 hemorrhagic fever in human and/or nonhuman primates with case mortality rates of up 50 to 90% (1) . There is one known species of Marburgvirus, Marburg marburgvirus, 51 consisting of two viruses, Marburg virus (MARV) and Ravn virus. On the other hand, 52
five distinct species are known in the genus Ebolavirus; Zaire ebolavirus, Sudan 53
ebolavirus, Taï forest ebolavirus, Bundibugyo ebolavirus, and Reston ebolavirus, 54 represented by Ebola virus (EBOV), Sudan virus (SUDV), Taï forest virus (TAFV), 55
Bundibugyo virus (BDBV), and Reston virus (RESTV), respectively. Among 56 ebolaviruses, a difference in pathogenicity was suggested. EBOV is thought to be the 57 most pathogenic, killing up to approximately 90% of patients, whereas RESTV has 58 never caused lethal infection in humans (2) and is less pathogenic in experimentally 59 infected nonhuman primates than EBOV (3). 60 and VP40 genes were synthesized according to the coding regions reported in the 117 database. Since the ebolavirus envelope GP is expressed through transcriptional editing 118 (21, 22) , the coding region of the GP gene was synthesized with an additional adenosine 119 at the putative editing site. After digestion by restriction enzymes, each gene was cloned 120 into mammalian expression vector pCAGGS (23). The expression plasmids for EBOV 121 (strain Mayinga), SUDV (strain Boniface), TAFV (strain Cote d'Ivoire), BDBV (strain 122 Bundibugyo), RESTV (strain Pennsylvania) and MARV (strains Angola and Musoke) 123 were constructed as described previously (24). 124 0.1 M phosphate buffer (pH 7.4) and postfixed with 1% osmium tetroxide in the same 166 buffer. The fixed samples were dehydrated with a series of ethanol gradients, substituted 167 with t-butanol, and dried in an ES-2030 freeze dryer (Hitachi). Dried specimens were 168 coated with platinum by using Mild spatter E-1046 (Hitachi). The samples were 169 observed with an S-4700 electron microscope (Hitachi) at 15 kV. 170
Vesicular stomatitis virus (VSV) pseudotyped with filovirus GPs. Using VSV 172
containing the green fluorescent protein (GFP) gene instead of the receptor-binding 173
VSV G protein gene (VSVΔG*-G)(6), pseudotyped viruses with GPs of EBOV, 174
RESTV, MARV strains Angola and Musoke, and LLOV (VSVΔG*-Zaire, 175 VSVΔG*-Reston, VSVΔG*-Angola, VSVΔG*-Musoke, and VSVΔG*-Lloviu, 176 respectively), were generated and the infectious units (IUs) of stock viruses were 177 determined in Vero E6 cells, according to a previous study (6) . The genome copy 178 number of each pseudotyped VSV preparation was quantified by real-time RT-PCR. 179
Real-time RT-PCR was performed using One Step SYBR PrimeScript RT-PCR Kit II 180 (TaKaRa Bio) and a CFX96 Real Time System (BIO RAD) with primers (GFP498-F: 181
CAAGATCCGCCACAACATCG and GFP-617R: GACTGGGTGCTCAGGTAGTG) 182
to detect the GFP gene in the VSV genome. Thus, we first analyzed the nucleotide and deduced amino acid sequences of LLOV GP, 216 and found that the nucleotide sequence of LLOV GP had 7 adenosines at positions 217 910-916. Based on sequence comparison with the EBOV genome, which has the editing 218 site at positions 880-816, we assumed that this stretch of 7 adenosines could be the 219 editing site of the LLOV GP gene. Accordingly, an open reading frame of the full 220 length transmembrane GP gene was produced by adding an adenosine at this putative 221 editing site (Fig.1A) . We found that LLOV envelope GP had a potential cleavage site 222 (i.e., RRRR recognized by host ubiquitous proteases such as furin) and MLR, similarly 223 to the other filoviruses. The predicted MLR of LLOV GP differed from that of EBOV 224 GP in length and location (i.e., LLOV MLR was located over the cleavage site and was 225 a little shorter than EBOV MLR) ( Fig. 1A and B) . We confirmed the approximate 226 molecular size of LLOV GP (GP 1, 2 , approximately 120-130 kD) and its cleavage 227 product, the GP 1 subunit (approximately 100 kD), by western blotting (Fig. 1C) . These 228 results suggested that LLOV GP principally might share biological characteristics with 229 the other filovirus GPs. 230 analyses revealed that LLOV VLPs were filamentous ( Fig. 2A and E), like EBOV (Fig.  236 2C and G) and MARV VLPs ( Fig. 2D and H) . Numerous spikes were observed on the 237 VLP surface and immuno-TEM with an anti-LLOV GP monoclonal antibody confirmed 238 the presence of LLOV GPs on the surface (Fig. 2B and F) . Similarly to the other 239 filoviruses (28), VLPs with a uniform diameter of approximately 70 nm and varied 240 lengths were observed. This was consistent with a previous study showing that the 241 diameters of VLPs were narrower than reported for actual EBOV particles (80-nm 242 diameter) (1, 29) . By SEM, numerous filamentous structures were observed on the 243 surfaces of cells transfected with plasmids expressing LLOV GP, VP40, and NP (Fig. 3) , 244 which has a similarity to EBOV budding (27). These results suggested that LLOV 245 shared morphological characteristics with the other known filoviruses. 246
247
Antigenic comparison among filovirus GPs. While LLOV is shown to be 248 phylogenically distinct from the other filovirus species, serological information is 249 lacking. The amino acid sequence of LLOV GP has 35% and 28% similarity with 250 EBOV and MARV, respectively. To compare the antigenic relationships among 251 filovirus GPs, we produced antisera to each GP by immunizing mice with VLPs, and 252 performed GP-based ELISA (Fig. 4) . We found that anti-LLOV GP sera showed 253 exclusive reactivity to the LLOV GP antigen (Fig. 4A) . Similarly, anti-MARV GP sera 254 only reacted with the MARV GP antigen (Fig. 4G ). Antisera to EBOV, SUDV, TAFV, 255 BDBV, and RESTV GPs showed slight cross-reactivity with ebolavirus antigens at the 256 lowest dilution of the sera but not with the LLOV and MARV GP antigens ( shown that endosomal acidification and proteolytic processing with the cellular cysteine 265 proteases cathepsin L and/or B are required for filovirus GP-mediated entry in vitro (6, 266 7, 30) . To investigate the requirement of these factors for the LLOV GP function, we 267 examined the infectivities of pseudotyped VSV in Vero E6 cells pretreated with 268 chemical inhibitors (Fig. 5) . Pretreatment of cells with ammonium chloride and 269 monensin markedly reduced the infectivity of VSVΔG*-Lloviu, as was the case with 270 VSVΔG*-Zaire, VSVΔG*-Angola, and VSVΔG*-G, suggesting that LLOV GP 271 requires a low pH for cellular entry. We found that pretreatments with a cathepsin L 272 inhibitor at concentrations of 2.5 and 10 μM significantly reduced the infectivities of 273 VSVΔG*-Lloviu, -Zaire, and -Angola. However, treatments at 0.625 μM did not show 274 any inhibitory effects on the VSVΔG*-Lloviu infectivity, and rather enhanced the 275 infectivity. Interestingly, when cells were treated with a cathepsin B inhibitor, the 276 infectivity of VSVΔG*-Zaire was reduced significantly in a dose-dependent manner, 277 whereas much less inhibition were observed in the VSVΔG*-Lloviu, -Zaire, and 278 -Angola infectivities. These cathepsin inhibitors did not affect the infectivity ofon the host cell surface are thought to serve as an attachment factor for filovirus GP, and 283 C-type lectin-mediated entry is believed to be one of the important factors responsible 284 for filovirus tropism and pathogenicity (11, 19, 20) . Thus, we investigated the potential 285 of LLOV GP to use the human C-type lectins hMGL and DC-SIGN, both of which are 286 known to enhance filovirus infectivity (Fig. 6 ). VSVΔG*-Lloviu infected 287 DC-SIGN-expressing cells more efficiently than hMGL-expressing cells, which was 288 similar to VSVΔG*-Zaire and VSVΔG*-Reston. VSVΔG*-Lloviu infected 289 hMGL-expressing cells more efficiently than VSVΔG*-Musoke (P < 0.05), but less 290 than VSVΔG*-Angola (P < 0.05), but there were no significant differences among 291 VSVΔG*-Lloviu, VSVΔG*-Zaire, and VSVΔG*-Reston. On the other hand, 292 VSVΔG*-Lloviu infected DC-SIGN-expressing cells more efficiently than 293 VSVΔG*-Angola (P < 0.05) and VSVΔG*-Musoke (P < 0.01), and less efficiently than 294 VSVΔG*-Zaire (P < 0.05), but there was no significant difference between 295 VSVΔG*-Lloviu and VSVΔG*-Reston. 296
297

Difference in ADE activity between anti-EBOV and anti-LLOVGP antisera. 298
Antibody-dependent enhancement of infection is also a known in vitro phenomenon 299 observed for comparatively highly lethal filoviruses (e.g., Zaire and Angola) (15, 31, 300 32). To investigate the potential of LLOV GP to induce ADE antibodies, K562 cells 301 were infected with VSVΔG*-Lloviu or VSVΔG*-Zaire in the presence of mouse 302 antisera specific to the respective viruses (Fig. 7) . We confirmed the ADE activity of the 303 anti-Zaire serum as indicated by markedly enhanced infectivities of VSVΔG*-Zaire at 304 the serum dilutions of 1:10 and 1:100 ( Fig 7A) . By contrast, only minimal ADE activitywere detected in both antisera by ELISA (Fig. 4) . Consist with the absence of 307 cross-reactive IgG in ELISA, little cross-ADE activity was observed in the ADE assay. 308 309 Cellular tropism of LLOV GP. To estimate the GP-dependent tropism that is likely 310 reflected by the prevalence of LLOV receptors, we infected various cell lines of 311 different animal origins (Table 1) with pseudotyped VSVs and their infectivities were 312 compared ( Fig. 8A ). VSVΔG*-Lloviu infected cells that were derived from the human, 313
African green monkey, pig, dog, and bat in a similar manner to VSVΔG*-Zaire and 314 VSVΔG*-Reston (Fig. 8A ). VSVΔG*-Angola and VSVΔG*-Musoke had higher IUs in 315 these cells than VSVΔG*-Lloviu, VSVΔG*-Zaire, and VSVΔG*-Reston, except in a 316 cell line from the Yaeyama flying fox (Pteropus dasymallus yayeyamae; FBKT1) (Fig  317   8A ). Since some species of bats are suspected to be natural reservoirs of filoviruses 318 (33-37), we focused on these bat cells and relative infectivities were determined (Fig.  319 8B). Interestingly, VSVΔG*-Lloviu infected IndFSPT1 and SuBK12-08 more 320
efficiently than the other viruses tested. 321
This study provides fundamental information on the properties of LLOV GP. 325
The RNA editing that is required to produce the full length transmembrane GP is a 326 common characteristic of viruses belonging to the genus Ebolavirus (21, 22). The 327 presence of the editing site in the LLOV GP gene supports the notion that this virus is 328 more related to ebolaviruses than marburgviruses. Phylogenic analyses also suggested 329 that LLOV might have the same ancestor as ebolaviruses (4). On the other hand, LLOV 330 GP has MLR and a furin cleavage site, both of which are common features shared by 331 previously known filoviruses (38, 39) . By TEM and SEM of VLPs, we further found 332 morphological similarity between LLOV and other filoviruses, which have numerous 333 GP spikes located on the filamentous VLP surface. Viral entry assays with chemical 334 inhibitors also suggest that LLOV GP, as well as GPs of the other filoviruses, requires 335 low endosomal pH and proteolytic processing for virus entry into cells. Taken together, 336 these results indicate that the structure and function of LLOV GP are primarily similar 337 to those of the other filovirus GPs. 338
However, the requirement of cathepsin L might be controversial since a high 339 concentration (> 1 μM) of FY-dmk was suggested to inhibit not only cathepsin L but 340 also cathepsins B and likely other endosomal cysteine proteases (40). FY-dmk at the 341 lowest concentration tested in this study (0.625 μM) did not reduce infectivities of 342 neither VSVΔG*-Lloviu, VSVΔG*-Zaire, nor VSVΔG*-Angola, suggesting that 343 cathepsin L is not essential for LLOV infection similarly to the other filoviruses (40, 41) . 344
It was also shown that Cathepsin B and Cathepsin L activities are not required for 345 EBOV replication in a mouse model (41). Thus, further studies are needed to clarify thein vivo importance of the GP cleavage by cathpsins and some other host proteases for 347 filovirus infection. 348
Hepatocytes, dendritic cells, monocytes, and macrophages, all of which express 349 cell surface C-type lectins, are thought to be the preferred target cells of filoviruses and 350 increased infection of these cells might be directly involved in the pathogenesis of 351 filovirus infection (11, 19, (42) (43) (44) . We demonstrated that LLOV GP utilized human 352 C-type lectins, hMGL and DC-SIGN, most likely as attachment factors, as reported with 353 the other filovirus GPs (13, 19, 20, 45 Like C-type lectins, ADE antibodies mostly recognize epitopes on MLR of 362 filovirus GPs, leading to enhanced infectivity (11, 13, 42) . Thus, MLR is thought to 363 play important roles for these two attachment functions of GP. In addition to the 364 primary structure of MLR (i.e., the presence of different epitopes and sugar chains 365 among filoviruses), the GP2 region seems to have key amino acid residues (e.g., the 366 amino acid at position 547 in MARV GP) contributing to the efficiency of ADE-and 367 C-type lectin-mediated entry (15, 20) . Although detailed functional mapping and 368 structural analysis are still needed, our data indicate that the overall properties of LLOVrather than highly virulent EBOV and MARV (strain Angola) (11, 13, 42) . 371 VSVΔG*-Lloviu infected all cell lines tested as well as VSVΔG*-Zaire and 372 VSVΔG*-Reston (Fig. 5A) . Recently, RESTV was detected in pigs in the Philippines 373
and China, and more recent studies have revealed that EBOV causes respiratory disease 374 in pigs (49-53), suggesting a potential role of this animal in filovirus ecology. In this 375 study, VSVΔG*-Lloviu infected pig cells (SK-L cells) in a similar manner to 376 VSVΔG*-Zaire and VSVΔG*-Reston. Although GP is not the only determinant 377 controlling filovirus pathogenicity, our data suggest that LLOV, at least, meets the 378 minimum requirements to infect pig cells. 379
Interestingly, neither VSVΔG*-Angola nor VSVΔG*-Musoke infected FBKT1 380 cells derived from the Yaeyama flying fox (Pteropus dasymallus yayeyamae), although 381 the infectivities of these viruses in the other cell lines tested were uniformly higher than 382 those of the other viruses (Fig.5A ). This finding suggests the existence of cellular 383 receptors/coreceptors that interacts with EBOV, RESTV, and LLOV GPs but not 384 MARV GP. Although several cellular molecules were reported to be involved in 385 filovirus entry (e.g., T-cell immunoglobulin domain and mucin domain 1, Tyro 3 family, 386 C-type lectin, or Niemann-Pick C1) (11-13, 42-47, 54-57) , there is only limited 387 information on these molecules in bats. It would be of interest to clarify whether these 388 cellular molecules play critical roles in tissue tropism and/or host range restriction of 389 filoviruses. Alternatively, there might be a new receptor of LLOV in bats. 390 VSVΔG*-Lloviu infected SuBK12-08 and IndFSPT1 more efficiently than the 391 other viruses (Fig. 5B) . It should be noted that SuBK12-08 was derived from the same 392 insectivorous bat species, Schreiber's bat (Miniopterus schreibersii), in which LLOVwas first detected in Europe. However, since LLOV likely causes lethal infection of 394 Schreiber's bat, this bat species may not serve as the natural host that can maintain this 395 virus in nature. On the other hand, IndFSPT1 was derived from fruit bats. Considering 396 that some species of fruit bats are suspected to be natural hosts of filoviruses (33, 58) , 397 strong tropism to this fruit bat species may suggest that fruit bats also play some roles in 398 the ecology of LLOV. 399
While LLOV seems to be highly pathogenic for some species of bats (e.g., 400
Schreiber's bat), its ability to infect human and nonhuman primates and the pathogenic 401 potential for these hosts can only be hypothesized, since infectious LLOV has never 402 been isolated. In this study, we used a replication-incompetent VSV pseudotype system 403 that enabled us to investigate the cellular tropism mediated by simple interaction 404 between LLOV GP and its cellular ligands. Although a reverse genetics approach and in 405 vivo experiments for infectious LLOV are needed to provide direct evidence of the viral 406 pathogenicity and host specificity, our data suggest that the overall properties of LLOV 407 GP are similar to those of the other filoviruses, and that LLOV has the potential, at least 408 from the aspect of GP-receptor/coreceptor interaction, to infect many mammalian cells, 409 including those of the human, monkey, and pig, with preferential tropism for some bat 410 cells. 
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e Nucleotide sequence identity is 100%.
6
f Nucleotide sequence identity is 89%.
7
g Nucleotide sequence identity is 98%. Fig. 1 Maruyama et al. 
